Recent developments in the perioperative management of the paediatric cardiac patient

Current Opinion in Anaesthesiology

Volumn 19, Issue 4, 2006, Pages 375-381

  Stocker, Christian F ^a,c,d   Shekerdemian, Lara S ^b,c  

^a Queensland Paediatric Intensive Care Service   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c Australia New Zealand Children's Heart Research Centre   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Cardiac surgery; Complications; Congenital heart disease

Indexed keywords

APROTININ; HEPARIN; LEVOSIMENDAN; LIOTHYRONINE; MILRINONE; OXYGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILDENAFIL; STEROID;

BLOOD GAS ANALYSIS; BRAIN INJURY; BRAIN PERFUSION; BRAIN PROTECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CONGENITAL HEART MALFORMATION; CYANOTIC HEART DISEASE; DOPPLER ECHOGRAPHY; DRUG COATING; DRUG DOSE REGIMEN; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; FOLLOW UP; FORWARD HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; LUNG FUNCTION; NEAR INFRARED SPECTROSCOPY; OPEN HEART SURGERY; OXYGEN THERAPY; PATIENT CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOSIS; ULTRAFILTRATION;

BRAIN DISEASES; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CHILD; HEART DISEASES; HEMOSTASIS; HEMOSTATICS; HUMANS; INFLAMMATION; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS;

EID: 33745914268     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aco.0000236135.77733.cd     Document Type: Review

References (98)

1. Redington AN. Protecting the heart and other organs after cardiac surgery: old problems, new solutions? Cardiol Young 2004; 14:182-191.
2. Webb CL, Jenkins KJ, Karpawich PP, et al. Collaborative care for adults with congenital heart disease. Circulation 2002; 105:2318-2323.
3. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89:57-64.
4. Bulutcu FS, Ozbek U, Polat B, et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Paediatr Anaesth 2005; 15:41-46.
5. Mossinger H, Dietrich W, Braun SL, et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003; 75:430-437.
6. Jaquiss RD, Ghanayem NS, Zacharisen MC, et al. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation 2002; 106 (12 Suppl 1):I90-I94.
7. Oliver WC Jr, Fass DN, Nuttall GA, et al. Variability of plasma aprotinin concentrations in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2004; 127:1670-1677.
8. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-365. A total of 4374 adult patients undergoing revascularization surgery were prospectively assessed in an observational multicentre, multicontinental study. A total of 1295 patients received aprotinin, 883 aminocaproic acid, 822 tranexamic acid, and 1374 no antifibrinolytic therapy. Overall, aprotinin significantly increased mortality and the risk for cerebrovascular, cardiovascular, and renal adverse events. After propensity adjustment, only renal events remained significantly higher in the aprotinin-treated patients. Given the large difference in significance before and after propensity adjustment, and the complete lack of control of unknown confounders, the results of the study must be appreciated with caution. Nevertheless, this study will lead to a significant decrease in the use of aprotinin in adult and paediatric cardiac surgical patients, last but not least due to considerable attention provoked in the legal community.
9. Tobias JD, Berkenbosch JW, Russo P. Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Med 2003; 4:49-51.
10. Pychynska-Pokorska M, Moll JJ, Krajewski W, Jarosik P. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Crit Care Med 2004; 5:246-250.
11. Egan JR, Lammi A, Schell DN, et al. Recombinant activated factor VII in paediatric cardiac surgery. Intensive Care Med 2004; 30:682-685.
12. Raivio P, Suojaranta-Ylinen R, Kuitunen AH. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery. Ann Thorac Surg 2005; 80:66-71.
13. Malagon I, Onkenhout W, Klok M, et al. Dexamethasone reduces gut permeability in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2005; 130:265-271.
14. Lindberg L, Forsell C, Jogi P, Olsson AK. Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery. Br J Anaesth 2003; 90:728-732.
15. Schroeder VA, Pearl JM, Schwartz SM, et al. Combined steroid treatment for congenital heart surgery improves oxygen delivery and reduces post-bypass inflammatory mediator expression. Circulation 2003; 107:2823-2828.
16. Checchia PA, Backer CL, Bronicki RA, et al. Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med 2003; 31:1742-1745.
17. Varan B, Tokel K, Mercan S, et al. Systemic inflammatory response related to cardiopulmonary bypass and its modification by methyl prednisolone: high dose versus low dose. Pediatr Cardiol 2002; 23:437-441.
18. Bronicki RA, Backer CL, Baden HP, et al. Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2000; 69:1490-1495.
19. Mott AR, Fraser CD Jr, Kusnoor AV, et al. The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. J Am Coll Cardiol 2001; 37:1700-1706.
20. Zhang S, Wang S, Li Q, et al. Capillary leak syndrome in children with C4A-deficiency undergoing cardiac surgery with cardiopulmonary bypass: a double-blind, randomised controlled study. Lancet 2005; 366:556-562. Randomized controlled trial in 116 neonates, infants, and children with CHD and complement component C4A deficiency undergoing open heart surgery. The patients were assigned to either C4A-free or C4A-rich fresh frozen plasma priming of the CPB circuit. Compared with 97% in the C4A-free priming group, only 5% of the patients developed a capillary leak syndrome in the C4A-rich priming group. Two of the C4A-free priming patients died of renal and respiratory failure on day 3 after CPB.
21. Ozawa T, Yoshihara K, Koyama N, et al. Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children. Ann Thorac Surg 2000; 69:584-590.
22. Grossi EA, Kallenbach K, Chau S, et al. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study. Ann Thorac Surg 2000; 70:191-196.
23. Horton SB, Butt WW, Mullaly RJ, et al. IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating. Ann Thorac Surg 1999; 68:1751-1755.
24. Elliott MJ. Ultrafiltration and modified ultrafiltration in pediatric open heart operations. Ann Thorac Surg 1993; 56:1518-1522.
25. Bando K, Turrentine MW, Vijay P, et al. Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg 1998; 66:821-827; discussion 828.
26. Berdat PA, Eichenberger E, Ebell J, et al. Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg 2004; 127:1688-1696.
27. Huang H, Yao T, Wang W, et al. Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg 2003; 76:136-140.
28. Chew MS, Brix-Christensen V, Ravn HB, et al. Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion 2002; 17:327-333.
29. Thompson LD, McElhinney DB, Findlay P, et al. A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2001; 122:220-228.
30. Parr GV, Blackstone EH, Kirklin JW. Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975; 51:867-874.
31. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995; 92:2226-2235.
32. Li JS, Bengur AR, Ungerleider RM, et al. Abnormal left ventricular filling after neonatal repair of congenital heart disease: association with increased mortality and morbidity. Am Heart J 1998; 136:1075-1080.
33. Cullen S, Shore D, Redington A. Characterization of right ventricular diastolic performance after complete repair of tetralogy of Fallot: restrictive physiology predicts slow postoperative recovery. Circulation 1995; 91:1782-1789.
34. Nunez S, Maisel A. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine. Am Heart J 1998; 135:383-388.
35. Duke T, Stocker C, Butt W. Monitoring children after cardiac surgery: a minimalist approach might be maximally effective. Crit Care Resusc 2004; 6:209-217.
36. 2). Lactate levels of less than 4 mmol/l on admission or less than 6 mmol/l on day 1 peak predicted adverse outcome with 73% sensitivity and 67% specificity, and positive and negative predictive values were 67% and 73%, respectively.
37. Duke T, Butt W, South M, Karl TR. Early markers of major adverse events in children after cardiac operations. J Thorac Cardiovasc Surg 1997; 114:1042-1052.
38. Charpie JR, Dekeon MK, Goldberg CS, et al. Serial blood lactate measurements predict early outcome after neonatal repair or palliation for complex congenital heart disease. J Thorac Cardiovasc Surg 2000; 120:73-80.
39. Hatherill M, Sajjanhar T, Tibby SM, et al. Serum lactate as a predictor of mortality after paediatric cardiac surgery. Arch Dis Child 1997; 77:235-238.
40. Rossi AF, Khan DM, Hannan R, et al. Goal-directed medical therapy and point-of-care testing improve outcomes after congenital heart surgery. Intensive Care Med 2005; 31:98-104.
41. Trittenwein G, Pansi H, Graf B, et al. Proposed entry criteria for postoperative cardiac extracorporeal membrane oxygenation after pediatric open heart surgery. Artif Organs 1999; 23:1010-1014.
42. Bellomo R, Uchino S. Cardiovascular monitoring tools: use and misuse. Curr Opin Crit Care 2003; 9:225-229.
43. Polonen P, Ruokonen E, Hippelainen M, et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg 2000; 90:1052-1059.
44. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377.
45. Li J, Schulze-Neick I, Lincoln C, et al. Oxygen consumption after cardiopulmonary bypass surgery in children: determinants and implications. J Thorac Cardiovasc Surg 2000; 119:525-533.
46. Dalrymple-Hay MJ, Deakin CD, Knight H, et al. Induced hypothermia as salvage treatment for refractory cardiac failure following paediatric cardiac surgery. Eur J Cardiothorac Surg 1999; 15:515-518.
47. Schwinn DA, Leone BJ, Spahn DR, et al. Desensitization of myocardial beta-adrenergic receptors during cardiopulmonary bypass: evidence for early uncoupling and late downregulation. Circulation 1991; 84:2559-2567.
48. Caspi J, Coles JG, Benson LN, et al. Age-related response to epinephrine-induced myocardial stress: a functional and ultrastructural study. Circulation 1991; 84 (5 Suppl):IH394-IH399.
49. Penny DJ, Sano T, Smolich JJ. Increased systemic oxygen consumption offsets improved oxygen delivery during dobutamine infusion in newborn lambs. Intensive Care Med 2001; 27:1518-1525.
50. Chang AC, Atz AM, Wernovsky G, et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995; 23:1907-1914.
51. Duggal B, Pratap U, Slavik Z, et al. Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect? Pediatr Cardiol 2005; 26:642-645.
52. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107:996-1002.
53. Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002; 360:196-202.
54. Follath F, Franco F, Cardoso JS. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Am J Cardiol 2005; 96 (6A):80G-85G.
55. Turanlahti M, Boldt T, Palkama T, et al. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery. Pediatr Crit Care Med 2004; 5:457-462.
56. Dimmick S, Badawi N, Randell T. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev 2004; 3:CD004220.
57. Mackie AS, Booth KL, Newburger JW, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005; 130:810-816. Forty-two neonates undergoing either a Norwood procedure or two-ventricle repair of interrupted aortic arch and ventricular septal defects were randomly assigned to receive a continuous infusion of T3 or placebo for 72 hours after CPB. Patients assigned to hormone treatment had shorter median time to negative fluid balance (2.0 versus 2.5 days, P = 0.027) and higher systolic blood pressure, whereas cardiac index, heart rate, and diastolic blood pressure were not influenced.
58. Weintraub RG, Brawn WJ, Venable AW, et al. Two-patch repair of complete atrioventricular septal defect in the first year of life: results and sequential assessment of atrioventricular valve function. J Thorac Cardiovasc Surg 1990; 99:320-326.
59. Goldman AP, Delius RE, Deanfield JE, et al. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension. Ann Thorac Surg 1996; 62:750-755.
60. Brown KL, Ridout DA, Goldman AP, et al. Risk factors for long intensive care unit stay after cardiopulmonary bypass in children. Crit Care Med 2003; 31:28-33.
61. Schulze-Neick I, Li J, Penny DJ, Redington AN. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 2001; 121:1033-1039.
62. Miller OI, Tang SF, Keech A, et al. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. Lancet 2000; 356:1464-1469.
63. Stocker C, Penny DJ, Brizard CP, et al. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med 2003; 29:1996-2003.
64. Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999; 91:307-310.
65. Atz AM, Lefler AK, Fairbrother DL, et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 2002; 124:628-629.
66. Thiagarajan RR, Nelson DP. Should we be satisfied with current outcomes for cardiac extracorporeal life support? Pediatr Crit Care Med 2005; 6:89-90.
67. Hintz SR, Benitz WE, Colby CE, et al. Utilization and outcomes of neonatal cardiac extracorporeal life support: 1996-2000. Pediatr Crit Care Med 2005; 6:33-38.
68. Cohen G, Permut L. Decision making for mechanical cardiac assist in pediatric cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2005; 41:41-50.
69. Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J 2005; 51:4-10.
70. Cengiz P, Seidel K, Rycus PT, et al. Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors. Crit Care Med 2005; 33:2817-2824.
71. Wernovsky G. Outcomes regarding the central nervous system in children with complex congenital cardiac malformations. Cardiol Young 2005; 15 (Suppl 1):132-133.
72. Baker EJ, Boerboom LE, Olinger GN, Baker JE. Tolerance of the developing heart to ischemia: impact of hypoxemia from birth. Am J Physiol 1995; 268 (3 Pt 2):H1165-H1173.
73. Taggart DP, Hadjinikolas L, Hooper J, et al. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J Thorac Cardiovasc Surg 1997; 113:728-735.
74. Imura H, Caputo M, Parry A, et al. Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circulation 2001; 103:1551-1556.
75. Karimi M, Wang LX, Hammel JM, et al. Neonatal vulnerability to ischemia and reperfusion: cardioplegic arrest causes greater myocardial apoptosis in neonatal lambs than in mature lambs. J Thorac Cardiovasc Surg 2004; 127:490-497.
76. Boiling K, Kronon M, Allen BS, et al. Myocardial protection in normal and hypoxically stressed neonatal hearts: the superiority of blood versus crystalloid cardioplegia. J Thorac Cardiovasc Surg 1997; 113:994-1003; discussion 1003-1005.
77. Kronon MT, Allen BS, Boiling KS, et al. The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection. Ann Thorac Surg 2000; 70:756-764.
78. Allen BS, Barth MJ, Ilbawi MN. Pediatric myocardial protection: an overview. Semin Thorac Cardiovasc Surg 2001; 13:56-72.
79. Modi P, Suleiman MS, Reeves B, et al. Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg 2004; 128:67-75.
80. Allen BS. Pediatric myocardial protection: a cardioplegic strategy is the "solution". Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004; 7:141-154.
81. Laussen PC, Murphy JA, Zurakowski D, et al. Bispectral index monitoring in children undergoing mild hypothermic cardiopulmonary bypass. Paediatr Anaesth 2001; 11:567-573.
82. Andropoulos DB, Stayer SA, McKenzie ED, Fraser CD Jr. Novel cerebral physiologic monitoring to guide low-flow cerebral perfusion during neonatal aortic arch reconstruction. J Thorac Cardiovasc Surg 2003; 125:491-499.
83. Zabala L, Ahmed MI. Denman WT. Bispectral index in a 3-year old undergoing deep hypothermia and circulatory arrest. Paediatr Anaesth 2003; 13:355-359.
84. Hayashida M, Chinzei M, Komatsu K, et al. Detection of cerebral hypoperfusion with bispectral index during paediatric cardiac surgery. Br J Anaesth 2003; 90:694-698.
85. Rappaport LA, Wypij D, Bellinger DC, et al. Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Boston Circulatory Arrest Study Group. Circulation 1998; 97:773-779.
86. Clancy RR, McGaurn SA, Wernovsky G, et al. Risk of seizures in survivors of newborn heart surgery using deep hypothermic circulatory arrest. Pediatrics 2003; 111:592-601.
87. Gaynor JW, Nicolson SC, Jarvik GP, et al. Increasing duration of deep hypothermic circulatory arrest is associated with an increased incidence of postoperative electroencephalographic seizures. J Thorac Cardiovasc Surg 2005; 130:1278-1286.
88. Mahle WT, Spray TL, Wernovsky G, et al. Survival after reconstructive surgery for hypoplastic left heart syndrome: a 15-year experience from a single institution. Circulation 2000; 102 (19 Suppl 3):III136-III141.
89. Forbess JM, Visconti KJ, Hancock-Friesen C, et al. Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation 2002; 106 (12 Suppl 1):I95-I102.
90. Wypij D, Newburger JW, Rappaport LA, et al. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 2003; 126:1397-1403.
91. Ungerleider RM, Gaynor JW. The Boston Circulatory Arrest Study: an analysis. J Thorac Cardiovasc Surg 2004; 127:1256-1261.
92. Hanley FL. Religion, politics ... deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2005; 130:1236.
93. du Plessis AJ, Jonas RA, Wypij D, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 1997; 114:991-1000; discussion 1000-1001.
94. Bellinger DC, Wypij D, du Plessis AJ, et al. Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 2001; 121:374-383.
95. Priestley MA, Golden JA, O'Hara IB, et al. Comparison of neurologic outcome after deep hypothermic circulatory arrest with alpha-stat and pH-stat cardiopulmonary bypass in newborn pigs. J Thorac Cardiovasc Surg 2001; 121:336-343.
96. Laussen PC. Optimal blood gas management during deep hypothermic paediatric cardiac surgery: alpha-stat is easy, but pH-stat may be preferable. Paediatr Anaesth 2002; 12:199-204.
97. Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg 2003; 126:1765-1774.
98. Warnes CA. The adult with congenital heart disease: born to be bad? J Am Coll Cardiol 2005; 46:1-8.